Medical Management of Endometriosis in Patients with Chronic Pelvic Pain

被引:48
作者
Bedaiwy, Mohamed A. [1 ]
Allaire, Catherine [1 ]
Yong, Paul [1 ]
Alfaraj, Sukinah [1 ]
机构
[1] Univ British Columbia, Div Reprod Endocrinol & Infertil, Dept Obstet & Gynecol, D415A-4500 Oak St, Vancouver, BC V6H 3N1, Canada
关键词
endometriosis; chronic pelvic pain; hormonal therapy; non-hormonal therapy; DEPOT MEDROXYPROGESTERONE ACETATE; HORMONAL ADD-BACK; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; RANDOMIZED CLINICAL-TRIAL; ORAL-CONTRACEPTIVE PILL; LONG-TERM TREATMENT; SYMPTOMATIC ENDOMETRIOSIS; INTRAUTERINE SYSTEM; LEUPROLIDE ACETATE; DOUBLE-BLIND;
D O I
10.1055/s-0036-1597308
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Endometriosis is a common cause of pelvic pain in women of reproductive age. Traditional medical therapies are hormonal in nature, including estrogen progestin contraceptives, progestins, and gonadotropin-releasing hormone (GnRH) agonists. Other hormonal options are androgens and aromatase inhibitors, with research also suggesting a possible role for GnRH antagonists and selective progesterone receptor modulators. Other than nonsteroidal anti-inflammatories, further work is required for nonhormonal therapies such as antiangiogenic and immune-modulating drugs. Medical treatment of endometriosis can be complex, and requires consideration of side effects, the anatomic type of endometriosis, role of surgery, current infertility or future fertility desires, and other contributors to pain (e.g., central sensitization). These factors should be discussed for each patient, to ensure personalized treatment and optimal outcomes.
引用
收藏
页码:38 / 53
页数:16
相关论文
共 115 条
[1]   Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery [J].
Abou-Setta, A. M. ;
Al-Inany, H. G. ;
Farquhar, C. M. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (04)
[2]   Deep endometriosis infiltrating the recto-sigmoid: critical factors to consider before management [J].
Abrao, Mauricio Simoes ;
Petraglia, Felice ;
Falcone, Tommaso ;
Keckstein, Joerg ;
Osuga, Yutaka ;
Chapron, Charles .
HUMAN REPRODUCTION UPDATE, 2015, 21 (03) :329-339
[3]   A comparison of the effect of short-term aromatase inhibitor (letrozole) and GnRH agonist (triptorelin) versus case control on pregnancy rate and symptom and sign recurrence after laparoscopic treatment of endometriosis [J].
Alborzi, Saeed ;
Hamedi, Bahareh ;
Omidvar, Azizeh ;
Dehbashi, Sedigheh ;
Alborzi, Soroosh ;
Alborzi, Mehrnoosh .
ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2011, 284 (01) :105-110
[4]   Combined Surgical and Hormone Therapy for Endometriosis is the Most Effective Treatment: Prospective, Randomized, Controlled Trial [J].
Alkatout, Ibrahim ;
Mettler, Liselotte ;
Beteta, Carmen ;
Hedderich, Juergen ;
Jonat, Walter ;
Schollmeyer, Thoralf ;
Salmassi, Ali .
JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY, 2013, 20 (04) :473-481
[5]   Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis [J].
Allen, Claire ;
Hopewell, Sally ;
Prentice, Andrew ;
Gregory, Daisy .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (02)
[6]  
Almassinokiani F, 2013, MED SCI MONITOR, V19, P534, DOI 10.12659/MSM.883967
[7]   Dienogest in the treatment of endometriosis: systematic review [J].
Andres, Marina de Paula ;
Lopes, Livia Alves ;
Baracat, Edmund Chada ;
Podgaec, Sergio .
ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2015, 292 (03) :523-529
[8]  
[Anonymous], 2016, Obstet Gynecol, V127, pe170, DOI 10.1097/AOG.0000000000001484
[9]   Aromatase inhibitors: the next generation of therapeutics for endometriosis? [J].
Attar, Erkut ;
Bulun, Serdar E. .
FERTILITY AND STERILITY, 2006, 85 (05) :1307-1318
[10]   HORMONE-TREATMENT OF ENDOMETRIOSIS - THE ESTROGEN THRESHOLD HYPOTHESIS [J].
BARBIERI, RL .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1992, 166 (02) :740-745